Skip to main content
. 2022 Oct 10;14(10):2156. doi: 10.3390/pharmaceutics14102156

Figure 4.

Figure 4

(A) MRI images and median values of the decrease in T1 and T2 weighted images in relation to the background signal for blood clots of 48, 24, 4, 1 h, and 0 h of age incubated with KCREKA-NPs, PEG-NPs, or PBS. (B) Number of positive pixels above the background signal for the T1 and T2 signals for blood clots of 48, 24, 4, 1 h, and 0 h of age incubated with KCREKA-NPs, PEG-NPs, or PBS. *** p < 0.001 using one way ANOVA followed by Kruskal-Wallis test.